Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek LeRoith

Showing results (141-150 of 304) with videos related to

Pageof 31
Sort By:
Plos One|March 8, 2011
Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanismsXiaosong Li, Xhiping Wu, Raul Camacho, et al.
The Journal of Family Practice|March 6, 2004
Type 2 diabetes: the role of basal insulin therapyDerek LeRoith, Claresa S Levetan, Irl B Hirsch, et al.
Endocrinology|July 10, 2004
Role of growth hormone (GH) in liver regenerationPatricia A Pennisi, John J Kopchick, Snorri Thorgeirsson, et al.
Diabetes|September 30, 2003
Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistanceMartin Haluzik, Shoshana Yakar, Oksana Gavrilova, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2017
Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR miceRasha Mosa, Lili Huang, Hongzhuo Li, et al.
Endocrinology|March 22, 2013
Investigating new therapeutic strategies targeting hyperinsulinemia's mitogenic effects in a female mouse breast cancer modelRan Rostoker, Keren Bitton-Worms, Avishay Caspi, et al.
The Journal of Biological Chemistry|March 24, 2004
TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survivalYuka Toyoshima, Michael Karas, Shoshana Yakar, et al.
Breast Cancer Research : BCR|May 16, 2016
CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapyRan Rostoker, Sarit Ben-Shmuel, Rola Rashed, et al.
Diabetes Care|May 22, 2016
Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory"William T Cefalu, Julio Rosenstock, Derek LeRoith, et al.
Endocrinology|December 25, 2004
Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivoHyunsook Kim, Elisabeth Barton, Naser Muja, et al.
Pageof 31

Showing results (141-150 of 304) with videos related to

Sort By:
Pageof 31
Plos One|March 8, 2011
Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanismsXiaosong Li, Xhiping Wu, Raul Camacho, et al.
The Journal of Family Practice|March 6, 2004
Type 2 diabetes: the role of basal insulin therapyDerek LeRoith, Claresa S Levetan, Irl B Hirsch, et al.
Endocrinology|July 10, 2004
Role of growth hormone (GH) in liver regenerationPatricia A Pennisi, John J Kopchick, Snorri Thorgeirsson, et al.
Diabetes|September 30, 2003
Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistanceMartin Haluzik, Shoshana Yakar, Oksana Gavrilova, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2017
Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR miceRasha Mosa, Lili Huang, Hongzhuo Li, et al.
Endocrinology|March 22, 2013
Investigating new therapeutic strategies targeting hyperinsulinemia's mitogenic effects in a female mouse breast cancer modelRan Rostoker, Keren Bitton-Worms, Avishay Caspi, et al.
The Journal of Biological Chemistry|March 24, 2004
TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survivalYuka Toyoshima, Michael Karas, Shoshana Yakar, et al.
Breast Cancer Research : BCR|May 16, 2016
CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapyRan Rostoker, Sarit Ben-Shmuel, Rola Rashed, et al.
Diabetes Care|May 22, 2016
Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory"William T Cefalu, Julio Rosenstock, Derek LeRoith, et al.
Endocrinology|December 25, 2004
Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivoHyunsook Kim, Elisabeth Barton, Naser Muja, et al.
Pageof 31